Dr David Lewis, director of aerosol research at pharmaceutical company Chiesi, discusses how the company is focusing on new technologies to advance drug discvoery and future-proof innovation.
research
Maintaining global consistency is an important part of the investment in technology, both in the laboratory and across research and development (R&D) locations. Replicating the same instrumentation and methods across sites allows different locations to easily share data and information, work, collaborate, and transfer methods more efficiently.